share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Intrater James

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities

Cardio Diagnostics | 4：持股變動聲明
SEC announcement ·  04/09 03:13
牛牛AI助理已提取核心訊息
James Intrater, associated with Cardio Diagnostics Holdings Inc. [CDIO], completed a purchase of 8,803 shares of common stock on March 31, 2024. The transaction was carried out at a price of $1.42 per share, resulting in a total investment of $12,500.26. Following this acquisition, Intrater's direct holdings in the company increased to 71,596 shares. The transaction is reported as an exercise or conversion of derivative security, indicating a potential increase in the insider's confidence in the company's future prospects.
James Intrater, associated with Cardio Diagnostics Holdings Inc. [CDIO], completed a purchase of 8,803 shares of common stock on March 31, 2024. The transaction was carried out at a price of $1.42 per share, resulting in a total investment of $12,500.26. Following this acquisition, Intrater's direct holdings in the company increased to 71,596 shares. The transaction is reported as an exercise or conversion of derivative security, indicating a potential increase in the insider's confidence in the company's future prospects.
與Cardio Diagnostics Holdings Inc.[ CDIO] 相關的詹姆斯·因特雷特於2024年3月31日完成了對8,803股普通股的購買。該交易以每股1.42美元的價格進行，總投資額爲12,500.26美元。此次收購後，Intrater在該公司的直接持股量增加到71,596股。該交易被報告爲行使或轉換衍生證券，表明內部人士對公司未來前景的信心可能會增強。
與Cardio Diagnostics Holdings Inc.[ CDIO] 相關的詹姆斯·因特雷特於2024年3月31日完成了對8,803股普通股的購買。該交易以每股1.42美元的價格進行，總投資額爲12,500.26美元。此次收購後，Intrater在該公司的直接持股量增加到71,596股。該交易被報告爲行使或轉換衍生證券，表明內部人士對公司未來前景的信心可能會增強。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。